Drawing for METLIFE ESTATE SAVER

USPTO serial 74120956

METLIFE ESTATE SAVER

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
MELTZER, ELEANOR
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with METLIFE ESTATE SAVER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alan Behr

ALAN BEHR METROPOLITAN LIFE INSURANCE COMPANYONE MADISON AVENEW YORK, NY 10010UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
036underwriting and administering life insuranceABANDONEDSep 1, 1990

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 28, 1993ABN1ABANDONMENT - EXPRESS MAILED—
Jan 22, 1993CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 1992CNSLLETTER OF SUSPENSION MAILED—
May 14, 1992CNSLLETTER OF SUSPENSION MAILED—
Mar 18, 1992CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 18, 1992CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 21, 1991CNSLLETTER OF SUSPENSION MAILED—
Jun 19, 1991CNEAEXAMINER'S AMENDMENT MAILED—
May 6, 1991DOCKASSIGNED TO EXAMINER—
Apr 26, 1991DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance